Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression
- PMID: 3977452
- PMCID: PMC1250740
- DOI: 10.1097/00000658-198504000-00016
Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression
Abstract
Although a thickness of less than or equal to 0.76 mm has been used to define biologically favorable (thin) melanoma, there is evidence that 1 mm may be a reasonable cutoff to categorize favorable extremity melanomas. This is tempered, however, by the claim that histologic regression in thin melanomas is associated with an increased metastatic rate. We have therefore addressed the following questions: Is 1 mm an appropriate cutoff point to define thin melanoma on the extremities? Does regression in a thin lesion truly signify a poor prognosis? Is the width of excision (narrow vs. wide) related to recurrence rates in these lesions? To address these issues we reviewed 48 patients with extremity melanomas, less than or equal to 1 mm in maximum thickness, treated at this institution during a 20-year period. Pathologic features included histologic type: superficial spreading (90%), nodular (6%), and not classified (4%); thickness: less than 0.76 mm (61%) and 0.76 to 1 mm (39%); and Clark's level: II (33%), III (63%), and IV (4%). A moderate or marked lymphoid infiltrate occurred in 75%, and histologic tumor regression was found in 50%. The median margin of excision, as stated by the surgeon, was 4 cm. The median margin measured by the pathologist in unfixed specimens was 3.5 cm. Although 13% had atypical melanocytic hyperplasia in the initial excisional biopsy margin, all reexcisions were clear. Of 21 patients having node dissections, none had nodal metastases. There were no recurrences or deaths due to melanoma (median follow-up: 90 months). We conclude that melanomas less than or equal to 1 mm in thickness on the extremities can be defined as biologically highly favorable, "thin" lesions. Foci of regression do not alter their behavior. Their favorable prognosis justifies conservative excision in most cases.
Similar articles
-
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).Cancer. 1975 Mar;35(3):666-76. doi: 10.1002/1097-0142(197503)35:3<666::aid-cncr2820350320>3.0.co;2-4. Cancer. 1975. PMID: 1111935
-
Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?Ann Plast Surg. 2003 Jun;50(6):601-6. doi: 10.1097/01.SAP.0000069065.00486.1E. Ann Plast Surg. 2003. PMID: 12783009
-
Surgical management of primary cutaneous melanomas of the hands and feet.Ann Surg. 1997 May;225(5):544-50; discussion 550-3. doi: 10.1097/00000658-199705000-00011. Ann Surg. 1997. PMID: 9193182 Free PMC article.
-
The nature of melanoma. A critical review.J Cutan Pathol. 1982 Apr;9(2):61-81. doi: 10.1111/j.1600-0560.1982.tb01044.x. J Cutan Pathol. 1982. PMID: 7047599 Review.
-
Malignant melanoma in the lower extremity. A comprehensive overview.Clin Podiatr Med Surg. 1986 Jul;3(3):533-50. Clin Podiatr Med Surg. 1986. PMID: 2943398 Review.
Cited by
-
The significance of inflammation and regression in melanoma.Virchows Arch A Pathol Anat Histopathol. 1992;420(2):113-5. doi: 10.1007/BF02358800. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1549899 No abstract available.
-
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.Cancer Immunol Immunother. 2008 Jan;57(1):97-106. doi: 10.1007/s00262-007-0353-9. Epub 2007 Jun 30. Cancer Immunol Immunother. 2008. PMID: 17602225 Free PMC article.
-
Cutaneous melanomas exhibiting unusual biologic behavior.World J Surg. 1992 Mar-Apr;16(2):196-202. doi: 10.1007/BF02071521. World J Surg. 1992. PMID: 1561799
-
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.Lab Invest. 2017 Jun;97(6):657-668. doi: 10.1038/labinvest.2017.8. Epub 2017 Feb 27. Lab Invest. 2017. PMID: 28240749
-
Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.Melanoma Res. 2012 Aug;22(4):302-9. doi: 10.1097/CMR.0b013e328353e673. Melanoma Res. 2012. PMID: 22610274 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical